Take Karikó, for example. Despite her persistence in pursuing mRNA research, she had no illusions that it was certain to work out. How could she, when she’d spent most of her career in risk-averse academia—a place more concerned, she thought, with getting the next grant than with inventing technologies that actually helped people—and
